Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations
Ramesh Kumar, Rajeev Nayan Priyadarshi, Utpal Anand
Journal of Clinical and Translational Hepatology (2019) Vol. X, Iss. X, pp. 1-11
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen Heyens, Dana Busschots, Ger H. Koek, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 161
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 135
Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease
Yuanqiang Ma, Gyurim Lee, Suyoung Heo, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 91-91
Open Access | Times Cited: 128
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
Eda Kaya, Yusuf Yılmaz
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 2, pp. 329-338
Open Access | Times Cited: 117
The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 87
Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
Menooa Ebrahimi, Seyed Arsalan Seyedi, Seyed Ali Nabipoorashrafi, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 52
Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults
Rui Song, Li Zhao, Yingzhi Zhang, et al.
Liver International (2024) Vol. 44, Iss. 4, pp. 1051-1060
Closed Access | Times Cited: 43
UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma
Junjie Xu, Lin Ji, Yeling Ruan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 83
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Veera Houttu, Susanne Csader, Max Nieuwdorp, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 70
Linearity and Bias of Proton Density Fat Fraction as a Quantitative Imaging Biomarker: A Multicenter, Multiplatform, Multivendor Phantom Study
Peng Hu, Takeshi Yokoo, Mustafa R. Bashir, et al.
Radiology (2021) Vol. 298, Iss. 3, pp. 640-651
Open Access | Times Cited: 55
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 10, pp. 2364-2405
Open Access | Times Cited: 38
The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
Qin Ling, Jiawei Chen, Xiao Liu, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 24
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 21
Bacteroides and NAFLD: pathophysiology and therapy
Jun Zhang, Jing Zhou, Zheyun He, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 9
Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials
Ehsan Amini‐Salehi, Sandeep Samethadka Nayak, Gautam Maddineni, et al.
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 5, pp. 2900-2910
Open Access | Times Cited: 7
Obesity and Obstructive Sleep Apnea
Maria R. Bonsignore
Handbook of experimental pharmacology (2021), pp. 181-201
Closed Access | Times Cited: 52
European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 663-720
Open Access | Times Cited: 36
Induction of lipid metabolism dysfunction, oxidative stress and inflammation response by tris(1-chloro-2-propyl)phosphate in larval/adult zebrafish
Yan Jin, Zijia Zhao, Min Xia, et al.
Environment International (2022) Vol. 160, pp. 107081-107081
Open Access | Times Cited: 35
Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States
Zhiqin Xie, Hongxia Li, Wenliang Tan, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 29
Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals
Azizullah Beran, Hazem Ayesh, Mohammed Mhanna, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2666-2666
Open Access | Times Cited: 29
DNA 5mC and RNA m6A modification successively facilitates the initiation and perpetuation stages of HSC activation in liver fibrosis progression
Yue Feng, Shihui Guo, Yulan Zhao, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1211-1220
Closed Access | Times Cited: 18
Model to predict major complications following liver resection for HCC in patients with metabolic syndrome
Giammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1527-1539
Closed Access | Times Cited: 16
Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD
Huanyi Cao, Qingxian Cai, Wanrong Guo, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112319-112319
Open Access | Times Cited: 16
Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis
Arnab Banerjee, Debasmita Das, Sandip Mukherjee, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112091-112091
Closed Access | Times Cited: 7
Non-alcoholic fatty liver disease and sleep disorders
Lu-Fang Bu, Chong-Yu Xiong, Jie-Yi Zhong, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 3, pp. 304-315
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top